By
Drug Target Review2023-12-21T16:00:45
Understanding the involvement of Nod1 in the development of blood stem cells could greatly improve blood disorder treatments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T07:00:00Z
2026-06-17T12:40:00Z
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-04-12T15:15:18
Sponsored by Cellistic
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2024-01-10T08:56:17
Sponsored by Leica Microsystems
Site powered by Webvision Cloud